Maria Grazia Spillantini, PhD

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Morris HR, Spillantini MG, Sue CM, et al. (2024) The pathogenesis of Parkinson's disease. Lancet (London, England). 403: 293-304
Goedert M, Crowther RA, Scheres SHW, et al. (2023) Tau and neurodegeneration. Cytoskeleton (Hoboken, N.J.)
Schweighauser M, Arseni D, Bacioglu M, et al. (2022) Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature
McMurray L, Macdonald JA, Ramakrishnan NK, et al. (2021) Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models. Acs Chemical Neuroscience
Goedert M, Spillantini MG, Falcon B, et al. (2021) Tau Protein and Frontotemporal Dementias. Advances in Experimental Medicine and Biology. 1281: 177-199
Migdalska-Richards A, Wegrzynowicz M, Harrison IF, et al. (2020) L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils. Plos One. 15: e0238075
Faustini G, Longhena F, Bruno A, et al. (2020) Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate. Neurobiology of Disease. 138: 104789
Kaalund SS, Passamonti L, Allinson KSJ, et al. (2020) Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity. Acta Neuropathologica Communications. 8: 11
Goedert M, Spillantini MG. (2019) Ordered Assembly of Tau Protein and Neurodegeneration. Advances in Experimental Medicine and Biology. 1184: 3-21
Schofield DJ, Irving L, Calo L, et al. (2019) Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo. Neurobiology of Disease. 104582